Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
NCT Number: NCT01635205
This study examines randomized triple-blind clinical trial and the efficacy of paraspinous anesthetic block on the treatment of chronic pelvic pain in patients non-responsive to pharmacological management. Sixty patients will be randomly divided and allocated into group intervention (paraspinous anesthetic block) and control (placebo procedure in subcutaneous tissue).
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 4
Porto Alegre, Rio Grande do Sul, Brazil
Patients will be allocated into one of two groups (intervention or placebo), and will be submitted to the corresponding procedure (paraspinous anesthetic block or placebo puncture in subcutaneous tissue). In the first appointment, pain will be measured with the VAS (Visual Analogue Scale); quality of life and function basal level will be evaluated by scales SF-36 (Medical Outcome Short-Form (36)Health Survey)and FSFI (Female Sexual Function Index), in Portuguese validated versions. Procedure will be realized as planned for each group.
Second appointment will occur one week after the procedure, and VAS scale will be applied.
Third appointment will occur in one month. VAS scale will be applied again,and procedure will be repeated if patient does not have a reduction of at least 30% of pain.
Next consultations will occur at two months, three months, four months and five months, with application of VAS scale to keep monitoring evolution of pain.
At six months of study, VAS scale will be applied along with SF-36 and FSFI questionnaires, to evaluate improvement in pain and in quality of life and function level.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Paraspinous anesthetic block with lidocaine 1% in sensitized segments of the thoracolumbar region
Subcutaneous puncture with injection needle (no substance will be injected)
Time frame: Change of pain from baseline at one week, at one month, at two months, at three months, at four months, at five months and at six months
Primary outcome is the reduction of pain, measured with the Visual Analogue Scale (VAS).
Time frame: At baseline and at six months
Quality of life will be evaluated with SF-36 scale at baseline and at six months, and scores will be compared at the end of the study.
Time frame: At baseline and at six months
Sexual function as a measure of functionality will be evalueted with the FSFI scale at baseline and at six months, and scores will be compared at the end of the study.
Hospital de Clinicas de Porto Alegre
Other
Efficacy of Paraspinous Anesthetic Block in Patients With Chronic Pelvic Pain Non-Responsive to Pharmacological Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02356796
Pelvis Pain Chronic
Tromsø, Troms, Norway
View Trial Details